View More View Less
  • 1 Semmelweis University Institute of Medical Microbiology Nagyvárad tér 4 H-1089 Budapest Hungary
  • | 2 Central Veterinary Institute Tábornok u. 2 H-1149 Budapest Hungary
  • | 3 University of Edinburgh Centre for Infectious Diseases Chancellor’s Building, 49 Little France Crescent Edinburgh EH16 4SB UK
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

In this report we examined the glycopeptide susceptibility of enterococci, isolated in 2005, from slaughtered animals, within the confines of Hungarian Antibiotic Resistance Monitoring System. We determined the presence of the van genes as well as their genetic relatedness in enterococci from poultry. Enterococcus sp. strains (n = 175) were collected from intestinal samples of slaughtered poultry in 2005. The origin of the samples was registered at county level. After screening the strains with 30 mg vancomycin disc 19 (86%) intermediate resistant and 4 (3%) fully resistant strains were found. The distribution of minimum inhibitory concentration (MIC)-values among 23 enterococcus strains which were intermediate or resistant to vancomycin were 0.25 mg/L (4.4%), 2 mg/L (8.6%), 4 mg/L (8.6%), 8 mg/L (61%), 16 mg/L (8.6%) and 256 mg/L (8.6%). The MICs of teicoplanin were 0.25 mg/L (4.3%), 1 (8.6%), 4 mg/L (78.3%), 16 mg/L (4.3%) and 256 mg/L (4.3%). The two most vancomycin-resistant strains were vanA carriers (1 E. faecalis and 1 E. faecium ).The farms that produced these strains can be reservoirs of VRE and the affected farms should change the technology of disinfection and breeding in order to prevent the emergence of high numbers of human VRE isolates in Hungary.

  • Ziglam, H. M., Finch, R. G.: Limitations of presently available glycopeptides in the treatment of Gram-positive infection. Clin Microbiol Infect 7 , 53–65 (2001).

    Finch R. G. , 'Limitations of presently available glycopeptides in the treatment of Gram-positive infection ' (2001 ) 7 Clin Microbiol Infect : 53 -65.

    • Search Google Scholar
  • Leclercq, R., Derlot, E., Duval, J., Courvalin, P.: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium . NEngl J Med 319 , 157–161 (1988).

    Courvalin P. , 'Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium ' (1988 ) 319 NEngl J Med : 157 -161.

    • Search Google Scholar
  • Uttley, A. H., Collins, C. H., Naidoo, J., George, R. C.: Vancomycin-resistant enterococci. Lancet 1 , 57–58 (1988).

    George R. C. , 'Vancomycin-resistant enterococci ' (1988 ) 1 Lancet : 57 -58.

  • French, G. L.: Enterococci and vancomycin resistance. Clin Infect Dis 27 , 75–83 (1998).

    French G. L. , 'Enterococci and vancomycin resistance ' (1998 ) 27 Clin Infect Dis : 75 -83.

  • Wegener, H. C., Aarestrup, F. M., Jensen, L. B., Hammerum, A. M., Bager, F.: Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 5 , 329–335 (1999).

    Bager F. , 'Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe ' (1999 ) 5 Emerg Infect Dis : 329 -335.

    • Search Google Scholar
  • Collignon, P. J.: Vancomycin-resistant enterococci and use of avoparcin in animal feed: is there a link? Med J Aust 171 , 144–146 (1999).

    Collignon P. J. , 'Vancomycin-resistant enterococci and use of avoparcin in animal feed: is there a link? ' (1999 ) 171 Med J Aust : 144 -146.

    • Search Google Scholar
  • Woodford, N.: Glycopeptide-resistant enterococci: a decade of experience. J Med Microbiol 47 , 849–862 (1998).

    Woodford N. , 'Glycopeptide-resistant enterococci: a decade of experience ' (1998 ) 47 J Med Microbiol : 849 -862.

    • Search Google Scholar
  • Williamson, R., Al-Obeid S., Shlaes, J. H., Goldstein, F. W., Shlaes, D. M.: Inducible resistance to vancomycin in Enterococcus faecium D366. J Infect Dis 159 , 1095–1104 (1989).

    Shlaes D. M. , 'Inducible resistance to vancomycin in Enterococcus faecium D366 ' (1989 ) 159 J Infect Dis : 1095 -1104.

    • Search Google Scholar
  • Leclercq, R., Dutka-Malen, S., Duval, J., Courvalin, P.: Vancomycin resistance gene vanC is specific to Enterococcus gallinarum . Antimicrob Agents Chemother 36 , 2005–2008 (1992).

    Courvalin P. , 'Vancomycin resistance gene vanC is specific to Enterococcus gallinarum ' (1992 ) 36 Antimicrob Agents Chemother : 2005 -2008.

    • Search Google Scholar
  • Perichon, B., Reynoldsm, P., Courvalin, P.: VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 41 , 2016–2018 (1997).

    Courvalin P. , 'VanD-type glycopeptide-resistant Enterococcus faecium BM4339 ' (1997 ) 41 Antimicrob Agents Chemother : 2016 -2018.

    • Search Google Scholar
  • Fines, M., Perichon, B., Reynolds, P., Sahm, D. F., Courvalin, P.: VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 43 , 2161–2164 (1999).

    Courvalin P. , 'VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405 ' (1999 ) 43 Antimicrob Agents Chemother : 2161 -2164.

    • Search Google Scholar
  • Depardieu, F., Bonora, M. G., Reynolds, P. E., Courvalin, P.: The van G glycopeptide resistance operon from Enterococcus faecalis revisited. Mol Microbiol 50 , 931–948 (2003).

    Courvalin P. , 'The vanG glycopeptide resistance operon from Enterococcus faecalis revisited ' (2003 ) 50 Mol Microbiol : 931 -948.

    • Search Google Scholar
  • Ghidán, A., Kaszanyitzky, E. J., Dobay, O., Nagy, K., Amyes, S. G., Rozgonyi, F.: Distribution and genetic relatedness of vancomycin-resistant enterococci (VRE) isolated from healthy slaughtered chickens in Hungary from 2001 to 2004. Acta Vet Hung 56 , 13–25 (2008).

    Rozgonyi F. , 'Distribution and genetic relatedness of vancomycin-resistant enterococci (VRE) isolated from healthy slaughtered chickens in Hungary from 2001 to 2004 ' (2008 ) 56 Acta Vet Hung : 13 -25.

    • Search Google Scholar
  • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 7 th ed.: Approved standard, M2-A7. Wayne, PA: NCCLS (2000).

    '', in Performance standards for antimicrobial disk susceptibility tests , (2000 ) -.

  • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement. M100-S12. NCCLS, Wayne, PA (2002).

    '', in Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement , (2002 ) -.

  • Deasy, B. M., Rea, M. C., Fitzgerald, G. F., Cogan, T. M., Beresford, T. P.: A rapid PCR based method to distinguish between lactococcus and enterococcus. Syst Appl Microbiol 23 , 510–522 (2000).

    Beresford T. P. , 'A rapid PCR based method to distinguish between lactococcus and enterococcus ' (2000 ) 23 Syst Appl Microbiol : 510 -522.

    • Search Google Scholar
  • Dutka-Malen, S., Evers, S., Courvalin, P.: Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33 , 24–27 (1995). Erratum in: J Clin Microbiol 33 , 1434 (1995).

    Courvalin P. , 'Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR ' (1995 ) 33 J Clin Microbiol : 24 -27.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
submission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Aug 2021 8 0 0
Sep 2021 6 0 0
Oct 2021 18 0 0
Nov 2021 5 0 0
Dec 2021 4 0 0
Jan 2022 1 1 1
Feb 2022 0 0 0